Leukaemia (chronic lymphocytic, first line) - rituximab: appraisal consultation (26th March 2009)
The Department of Health asked the National Institute for Health and Clinical Excellence (NICE or the Institute) to conduct a single technology appraisal (STA) of rituximab for the first-line treatment of chronic lymphocytic leukaemia and provide guidance on its use to the NHS in England and Wales. The Appraisal Committee has had its first meeting to consider both the evidence submitted by the manufacturer and the views put forward by non-manufacturer consultees and commentators, and by the clinical specialist and patient expert representatives nominated for this appraisal by non-manufacturer consultees and commentators. The Committee has developed preliminary recommendations on the use of rituximab. Closing date for comments is 20th April 2009.
Consultation
Hip fracture: draft scope consultation (1st April 2009)
NICE have been asked to develop a clinical practice guideline on the management of femoral neck fractures for use in the NHS in England, Wales and Northern Ireland. The draft scope defines what aspects of care the guideline will cover and to whom it will apply. Closing date for comments is 29th April 2009.
Consultation
Stable angina: draft scope consultation (2nd April 2009)
NICE have been asked to develop a clinical practice guideline on the stable angina for use in the NHS in England, Wales and Northern Ireland. The draft scope defines what aspects of care the guideline will cover and to whom it will apply. Closing date for comments is 30th April 2009.
Consultation
Weight management following childbirth: draft scope consultation (6th April 2009)
NICE is developing public health intervention guidance for weight management following childbirth. Closing date for comments is 11th May 2009.
Consultation
The Department of Health asked the National Institute for Health and Clinical Excellence (NICE or the Institute) to conduct a single technology appraisal (STA) of rituximab for the first-line treatment of chronic lymphocytic leukaemia and provide guidance on its use to the NHS in England and Wales. The Appraisal Committee has had its first meeting to consider both the evidence submitted by the manufacturer and the views put forward by non-manufacturer consultees and commentators, and by the clinical specialist and patient expert representatives nominated for this appraisal by non-manufacturer consultees and commentators. The Committee has developed preliminary recommendations on the use of rituximab. Closing date for comments is 20th April 2009.
Consultation
Hip fracture: draft scope consultation (1st April 2009)
NICE have been asked to develop a clinical practice guideline on the management of femoral neck fractures for use in the NHS in England, Wales and Northern Ireland. The draft scope defines what aspects of care the guideline will cover and to whom it will apply. Closing date for comments is 29th April 2009.
Consultation
Stable angina: draft scope consultation (2nd April 2009)
NICE have been asked to develop a clinical practice guideline on the stable angina for use in the NHS in England, Wales and Northern Ireland. The draft scope defines what aspects of care the guideline will cover and to whom it will apply. Closing date for comments is 30th April 2009.
Consultation
Weight management following childbirth: draft scope consultation (6th April 2009)
NICE is developing public health intervention guidance for weight management following childbirth. Closing date for comments is 11th May 2009.
Consultation
No comments:
Post a Comment